Your browser doesn't support javascript.
loading
Initiation of HIV neutralizing B cell lineages with sequential envelope immunizations.
Williams, Wilton B; Zhang, Jinsong; Jiang, Chuancang; Nicely, Nathan I; Fera, Daniela; Luo, Kan; Moody, M Anthony; Liao, Hua-Xin; Alam, S Munir; Kepler, Thomas B; Ramesh, Akshaya; Wiehe, Kevin; Holland, James A; Bradley, Todd; Vandergrift, Nathan; Saunders, Kevin O; Parks, Robert; Foulger, Andrew; Xia, Shi-Mao; Bonsignori, Mattia; Montefiori, David C; Louder, Mark; Eaton, Amanda; Santra, Sampa; Scearce, Richard; Sutherland, Laura; Newman, Amanda; Bouton-Verville, Hilary; Bowman, Cindy; Bomze, Howard; Gao, Feng; Marshall, Dawn J; Whitesides, John F; Nie, Xiaoyan; Kelsoe, Garnett; Reed, Steven G; Fox, Christopher B; Clary, Kim; Koutsoukos, Marguerite; Franco, David; Mascola, John R; Harrison, Stephen C; Haynes, Barton F; Verkoczy, Laurent.
Afiliación
  • Williams WB; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Zhang J; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Jiang C; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Nicely NI; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Fera D; Boston Children's Hospital and Harvard Medical School, Boston, MA, 02115, USA.
  • Luo K; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Moody MA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Liao HX; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Alam SM; College of Life Science and Technology, Jinan University, Guangzhou, 510632, China.
  • Kepler TB; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Ramesh A; Boston University School of Medicine, Boston, MA, 02118, USA.
  • Wiehe K; Boston University School of Medicine, Boston, MA, 02118, USA.
  • Holland JA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Bradley T; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Vandergrift N; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Saunders KO; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Parks R; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Foulger A; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Xia SM; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Bonsignori M; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Montefiori DC; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Louder M; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Eaton A; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, 20892, USA.
  • Santra S; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Scearce R; Boston Children's Hospital and Harvard Medical School, Boston, MA, 02115, USA.
  • Sutherland L; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Newman A; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Bouton-Verville H; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Bowman C; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Bomze H; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Gao F; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Marshall DJ; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Whitesides JF; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Nie X; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Kelsoe G; Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, NC, 27157, USA.
  • Reed SG; Department of Immunology, Duke University, Durham, NC, 27710, USA.
  • Fox CB; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Clary K; Department of Immunology, Duke University, Durham, NC, 27710, USA.
  • Koutsoukos M; Infectious Disease Research Institute, Seattle, WA, 98102, USA.
  • Franco D; Infectious Disease Research Institute, Seattle, WA, 98102, USA.
  • Mascola JR; Infectious Disease Research Institute, Seattle, WA, 98102, USA.
  • Harrison SC; GSK Vaccines, Rixensart, 1330, Belgium.
  • Haynes BF; GSK Vaccines, Rixensart, 1330, Belgium.
  • Verkoczy L; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, 20892, USA.
Nat Commun ; 8(1): 1732, 2017 11 23.
Article en En | MEDLINE | ID: mdl-29170366

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos B / Anticuerpos Anti-VIH / VIH-1 / Productos del Gen env del Virus de la Inmunodeficiencia Humana / Anticuerpos Neutralizantes Límite: Animals / Female / Humans / Male Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos B / Anticuerpos Anti-VIH / VIH-1 / Productos del Gen env del Virus de la Inmunodeficiencia Humana / Anticuerpos Neutralizantes Límite: Animals / Female / Humans / Male Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos